These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16929490

  • 1. Circulating enterolactone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A, Lundin E, Micheli A, Koenig KL, Lenner P, Muti P, Shore RE, Johansson I, Krogh V, Lukanova A, Stattin P, Afanasyeva Y, Rinaldi S, Arslan AA, Kaaks R, Berrino F, Hallmans G, Toniolo P, Adlercreutz H.
    Int J Cancer; 2006 Nov 15; 119(10):2376-81. PubMed ID: 16929490
    [Abstract] [Full Text] [Related]

  • 2. Circulating enterolactone and risk of breast cancer: a prospective study in New York.
    Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, Toniolo P.
    Br J Cancer; 2004 Jul 05; 91(1):99-105. PubMed ID: 15226762
    [Abstract] [Full Text] [Related]

  • 3. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.
    Kilkkinen A, Virtamo J, Vartiainen E, Sankila R, Virtanen MJ, Adlercreutz H, Pietinen P.
    Int J Cancer; 2004 Jan 10; 108(2):277-80. PubMed ID: 14639615
    [Abstract] [Full Text] [Related]

  • 4. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
    Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr 10; 10(4):339-44. PubMed ID: 11319174
    [Abstract] [Full Text] [Related]

  • 5. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
    Aarestrup J, Kyrø C, Knudsen KE, Weiderpass E, Christensen J, Kristensen M, Würtz AM, Johnsen NF, Overvad K, Tjønneland A, Olsen A.
    Br J Nutr; 2013 Jun 28; 109(12):2269-75. PubMed ID: 23114205
    [Abstract] [Full Text] [Related]

  • 6. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
    Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, Pietinen P.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 28; 12(11 Pt 1):1209-12. PubMed ID: 14652283
    [Abstract] [Full Text] [Related]

  • 7. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, Kaaks R, Chang-Claude J.
    Int J Cancer; 2012 Mar 15; 130(6):1401-10. PubMed ID: 21544804
    [Abstract] [Full Text] [Related]

  • 8. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
    Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M.
    Int J Cancer; 2002 May 01; 99(1):124-9. PubMed ID: 11948503
    [Abstract] [Full Text] [Related]

  • 9. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, Kaaks R, Linseisen J, Obi N, Heinz J, Flesch-Janys D, Chang-Claude J.
    Int J Cancer; 2014 Aug 15; 135(4):923-33. PubMed ID: 24436155
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
    Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A.
    Int J Cancer; 2004 Jan 20; 108(3):425-32. PubMed ID: 14648710
    [Abstract] [Full Text] [Related]

  • 12. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
    Stuedal A, Gram IT, Bremnes Y, Adlercreutz H, Veierød MB, Ursin G.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 20; 14(9):2154-9. PubMed ID: 16172225
    [Abstract] [Full Text] [Related]

  • 13. An incident case-referent study on plasma enterolactone and breast cancer risk.
    Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G.
    Eur J Nutr; 2002 Aug 20; 41(4):168-76. PubMed ID: 12242585
    [Abstract] [Full Text] [Related]

  • 14. Validation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women.
    Lin Y, Wolk A, Håkansson N, Peñalvo JL, Lagergren J, Adlercreutz H, Lu Y.
    Br J Nutr; 2013 May 28; 109(10):1873-80. PubMed ID: 23006454
    [Abstract] [Full Text] [Related]

  • 15. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
    Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Grönberg H, Bälter KA.
    Cancer Causes Control; 2006 Mar 28; 17(2):169-80. PubMed ID: 16425095
    [Abstract] [Full Text] [Related]

  • 16. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.
    Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT.
    Lancet; 2006 Mar 28; 354(9196):2112-5. PubMed ID: 10609816
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
    Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H.
    Cancer Causes Control; 2004 Dec 28; 15(10):1095-102. PubMed ID: 15801493
    [Abstract] [Full Text] [Related]

  • 19. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
    Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 1998 Oct 28; 7(10):885-9. PubMed ID: 9796633
    [Abstract] [Full Text] [Related]

  • 20. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Møller S, Tjønneland A.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 28; 13(12):2084-9. PubMed ID: 15598765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.